BioNTech SE (BNTX) Reports Q2 EPS of EUR6.45

BioNTech SE (NASDAQ: BNTX) reported Q2 EPS of EUR6.45. Revenue for the quarter came in at EUR3.2 billion.

The company reiterated BioNTech COVID-19 2022 vaccine revenue guidance of €13 billion to €17 billion.

For earnings history and earnings-related data on BioNTech SE (BNTX) click here.

You May Also Be Interested In

• Baird on Nurix (NRIX) Earnings Amid 7% Drop: '2Q Print Solid as Breadth of Development Expands'
• BioNTech (BNTX) PT Lowered to $119 at Morgan Stanley
• Raymond James Previews Charles Schwab Corp. (SCHW) Earnings: 'Elevated Trading Volumes Drives Trading Revenue Upside'